Methods and Compositions for Modulating Gene Expression
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2017/050553, filed Sep 7, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,624,065 | Methods and Compositions for Modulating Gene Expression In force · Medium confidence UsedRemaining | Flagship Pioneering Innovations V, Inc. | In force | Medium confidence | ||
| US 11,312,955 | Methods and Compositions for Modulating Gene Expression In force · Medium confidence | Flagship Pioneering Innovations V, Inc. | In force | Medium confidence | ||
| US 12,509,683 | Methods and Compositions for Modulating Gene Expression In force · Low confidence | Flagship Pioneering Innovations V, Inc. | In force | Low confidence | ||
| US 12,522,823 | Methods and Compositions for Modulating Gene Expression In force · Low confidence | Flagship Pioneering Innovations V, Inc. | In force | Low confidence | ||
| Application 16/330,999 | Methods and Compositions for Modulating Gene Expression Abandoned Abandoned Mar 2, 2020 | Flagship Pioneering Inc. | Abandoned | Abandoned Mar 2, 2020 | ||
| Application 19/414,635 | Methods and Compositions for Modulating Gene Expression Pending Not granted | Flagship Pioneering Innovations V, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Flagship Pioneering, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.